October 14th, 2015
Event starts time:
Dr Finnegan introduces a pilot clinical trial underway at St. Patrick’s University Hospital which is exploring the use of the drug Ketamine for relapse prevention following successful Electroconvulsive therapy (ECT). This study will be of particular interest to individuals who experience severe clinical depression and who have high incidence of relapse. The aim of the research team is to offer patients a sustained period of wellness and improve the quality of life during this period.
Available Monday to Sunday from 10am to 10pmMore Information
Aware Support & Self Care Groups offer a unique opportunity to talk openly about depression or bipolar disorder and its impact.More information
Sign up to the Aware Newsletter by email to receive updates on Aware’s programmes, events, campaigns, services, volunteering opportunities & more...